Polyomavirus enhancer requirements for expression in embryonal carcinoma cells
- PMID: 8389574
Polyomavirus enhancer requirements for expression in embryonal carcinoma cells
Abstract
Wild type polyomavirus expression is suppressed in embryonal carcinoma (EC) cell lines. This suppression is alleviated when the EC cells are induced to differentiate. Several characterized host range mutants of polyoma overcome suppression and are able to express and replicate in the undifferentiated EC cells. These previously described isolates were obtained by serial passage of a wild type strain through PCC4 or F9 EC lines. We present a new pyPCC4 isolate (LPT) derived without selection in EC cells. Isolates with host range specificity for a given EC line have been reported to share several common rearrangements and features. These features are also observed in LPT. We report a novel feature shared by these mutants, including LPT, capable of expression in the EC cell line PCC4. In 8 of 10 isolates a novel sequence is created within the enhancer region by rearrangement junctions with near perfect homology to the AP-1 core consensus sequence, 'TGACT(C/A)A'. That the precise location of these junctions varies among these isolates suggest a functional role for this conserved sequence. Our goal is to understand the function of various mutations in host range mutants of polyoma. In order to understand the rearrangements necessary for expression and replication of polyoma in PCC4 cells, we have further characterized the limits of the B enhancer in these cells as compared to those described in permissive cell systems. We have been able to locate the origin proximal limit of the B enhancer for replication close to nt 5189 and distinguish it from the origin proximal limit of the B enhancer for transcription near nt 5215. The two B enhancer cores overlap but do not coincide and are conserved in both cell lines.
Similar articles
-
Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.Virology. 1994 Aug 1;202(2):724-34. doi: 10.1006/viro.1994.1394. Virology. 1994. PMID: 8030236
-
Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.Nature. 1987 Jul 16-22;328(6127):254-6. doi: 10.1038/328254a0. Nature. 1987. PMID: 3037385
-
A factor discriminating between the wild-type and a mutant polyomavirus enhancer.Nature. 1987 Jul 2-8;328(6125):87-9. doi: 10.1038/328087a0. Nature. 1987. PMID: 3037380
-
RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.Adv Cancer Res. 2008;99:33-76. doi: 10.1016/S0065-230X(07)99002-8. Adv Cancer Res. 2008. PMID: 18037406 Review.
-
The nature of the host range restriction of SV40 and polyoma viruses in embryonal carcinoma cells.Curr Top Microbiol Immunol. 1982;101:1-30. doi: 10.1007/978-3-642-68654-2_1. Curr Top Microbiol Immunol. 1982. PMID: 6303700 Review. No abstract available.
Cited by
-
Transcription enhancers as major determinants of SV40 polyomavirus growth efficiency and host cell tropism.J Gen Virol. 2016 Jul;97(7):1597-1603. doi: 10.1099/jgv.0.000487. Epub 2016 Apr 21. J Gen Virol. 2016. PMID: 27100458 Free PMC article.
-
Receptor-binding and oncogenic properties of polyoma viruses isolated from feral mice.PLoS Pathog. 2007 Dec;3(12):e179. doi: 10.1371/journal.ppat.0030179. PLoS Pathog. 2007. PMID: 18085820 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous